Internal Medicine, Pulmonary Disease · Chicago, IL
NPI
1619293800
Since 2010
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1740 W Taylor St
Chicago, IL, 60612
Phone (866) 600-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
1,439 services
Medicare patients, 2024
504
Average age 71
Drug cost, 2024
$2.0M
1,427 prescriptions
Company payments, 2025
$2,198
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abhaya P Trivedi was code 94726 (pulmonary function testing), 188 times for 187 patients. In total Abhaya P Trivedi billed 1,439 services in 31 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94726 Pulmonary Function Testing | Facility | 188 | 187 | $8.95 | $1,682 |
| 94375 Pulmonary Function Testing | Facility | 185 | 180 | $10.55 | $1,952 |
| 94729 Pulmonary Function Testing | Facility | 185 | 184 | $6.69 | $1,238 |
| 99291 Critical Care E&M | Facility | 161 | 71 | $174.31 | $28K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 121 | 88 | $13.47 | $1,630 |
| 99215 Office E&M - Established | Facility | 108 | 67 | $110.40 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 97 | 50 | $97.50 | $9,458 |
| 99214 Office E&M - Established | Facility | 95 | 73 | $74.12 | $7,041 |
| 94060 Pulmonary Function Testing | Facility | 77 | 77 | $7.52 | $579 |
| 94729 Pulmonary Function Testing | Office | 24 | 23 | $16.15 | $388 |
| 99443 Telephone Services | Office | 24 | 20 | $91.10 | $2,186 |
| 94726 Pulmonary Function Testing | Office | 22 | 21 | $16.76 | $369 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 13 | $64.92 | $1,298 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $142.51 | $2,423 |
| 94375 Pulmonary Function Testing | Office | 16 | 15 | $13.71 | $219 |
By year: 2022 $103K for 1,501 services; 2023 $70K for 1,069 services; 2024 $78K for 1,439 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abhaya P Trivedi prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 340 prescriptions and refills. In total Abhaya P Trivedi wrote 1,427 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 340 | 386 | 64 | $241K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 191 | 231 | 58 | $6,052 |
| Tezspire Tezepelumab-Ekko | 159 | 159 | 21 | $684K |
| Prednisone Generic | 82 | 82 | 38 | $173 |
| Azithromycin Generic | 44 | 49 | 19 | $233 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 40 | 56 | 13 | $7,630 |
| Ventolin Hfa Albuterol Sulfate | 40 | 48 | 11 | $3,018 |
| Dupixent Pen Dupilumab | 39 | 43 | Under 11 | $155K |
| Fluticasone Propionate Generic | 38 | 78 | 20 | $527 |
| Fasenra Pen Benralizumab | 36 | 65 | Under 11 | $197K |
| Symbicort Budesonide/Formoterol Fumarate | 29 | 36 | Under 11 | $7,873 |
| Azelastine Hcl Generic | 29 | 48 | 11 | $740 |
| Breo Ellipta Fluticasone/Vilanterol | 28 | 28 | Under 11 | $11K |
| Omeprazole Generic | 26 | 48 | Under 11 | $149 |
| Nucala Mepolizumab | 22 | 27 | Under 11 | $192K |
Brand drugs: 1,041 claims; generic drugs: 386 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abhaya P Trivedi $2,198 ($2,198 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genzyme Corporation with $2,168.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.